Literature DB >> 6085228

Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.

C S Raine, U Traugott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085228     DOI: 10.1111/j.1749-6632.1984.tb14774.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

Authors:  D Gambi; T Fulgente; D Melchionda; M Onofrj
Journal:  Ital J Neurol Sci       Date:  1996-02

Review 2.  Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

Authors:  A Rouleau; V Dimitriadou; M D Trung Tuong; G F Newlands; H R Miller; J C Schwartz; M Garbarg
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  E Mix; T Olsson; J Correale; S Baig; V Kostulas; O Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging.

Authors:  Shu-Wei Sun; Hsiao-Fang Liang; Robert E Schmidt; Anne H Cross; Sheng-Kwei Song
Journal:  Neurobiol Dis       Date:  2007-06-23       Impact factor: 5.996

5.  Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.

Authors:  Orhan Aktas; Sonia Waiczies; Alina Smorodchenko; Jan Dorr; Bibiane Seeger; Timour Prozorovski; Stephanie Sallach; Matthias Endres; Stefan Brocke; Robert Nitsch; Frauke Zipp
Journal:  J Exp Med       Date:  2003-03-10       Impact factor: 14.307

Review 6.  Multiple sclerosis: basic concepts and hypothesis.

Authors:  M Rodriguez
Journal:  Mayo Clin Proc       Date:  1989-05       Impact factor: 7.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.